Opioid Prescribing to US Children and Young Adults in 2019
Recent national data are lacking on the prevalence, safety, and prescribers of opioid prescriptions dispensed to children and young adults aged 0 to 21 years. More
Publications
TYPE
ISSUE
TAG
The FDA Is Broken
How the Food and Drug Administration messes up approval of new drugs including the new one, aducanumab, that supposedly helps Alzheimer’s disease patients. More
Use of term ‘low value’ may leave Black, Latinx patients with questions about access to care
This is the second of two articles on reframing the debate about low-benefit treatments. More
After company protest, FDA agrees to review controversial drug to prevent premature birth
“This drug needs to be pulled off the market — period," said Adam Uratro, the chief of maternal-fetal medicine at MetroWest Medical Center. More